AZ Will Sideline ‘Lucky Mistake’ Data To Secure COVID-19 Vaccine Approval
UK Regulator Asked To Get On With Review; US Unlikely To Accept Data
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.
